Clinical trials & evidence

When Brain Surgery Is Too Risky, Patients Still Need a Molecular Answer

A Rare Childhood Ataxia Gets Real Phase III Evidence

Europe’s next stroke bet: can Factor XIa inhibition change prevention without raising bleeding risk?

MASH, a serious fatty liver disease, is becoming a cardiometabolic condition

Cervical Cancer Cannot Be Left Waiting at the Edge of the ADC Era

Do Not Turn Cancer Trials Into Political Collateral

ESC Cardio-Oncology 2026: Cancer therapy is getting smarter. Cardiac protection is still playing catch-up.

ENDO 2026 reveals the GLP-1 revolution’s real challenge: delivery

Gastric Cancer Gets a New Biomarker Access Signal
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
